Back
Constellation Software Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
74
CSU.TO
Constellation Software
Last Price:
3,876.95
Seasonality Move:
5.89%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.82
Seasonality Move:
-0.9%
Buy
74
Constellation Software (CSU.TO)
is a Buy
Is Constellation Software a Buy, Sell or Hold?
- The current Constellation Software [CSU.TO] share price is $3,876.95. The Score for CSU.TO is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- CSU.TO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CSU.TO Stock Price Chart
What is Constellation Software's stock price today?
-
The Constellation Software share price today is $3,876.95
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CSU.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
CSU.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 23.58 | Buy |
Relative Strength Index (14 RSI): | 60.03 | Buy |
Chaikin Money Flow: | 17345 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3746.54 - 3838.3) | Buy |
Bollinger Bands (100): | (3646.66 - 3799.74) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.7 | Sell |
Relative Strength Index (14 RSI): | 46.74 | Sell |
Chaikin Money Flow: | 84619 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.82 - 42.02) | Sell |
Bollinger Bands (100): | (40.86 - 48.8) | Sell |
CSU.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3800.02 | Buy |
20-day SMA: | 3802.92 | Buy |
50-day SMA: | 3737.41 | Buy |
200-day SMA: | 3423.65 | Buy |
8-day EMA: | 3817.86 | Buy |
20-day EMA: | 3796.25 | Buy |
50-day EMA: | 3753.05 | Buy |
200-day EMA: | 3446.77 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.53 | Buy |
20-day SMA: | 40.36 | Sell |
50-day SMA: | 41.57 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.71 | Buy |
20-day EMA: | 40.38 | Sell |
50-day EMA: | 41.84 | Sell |
200-day EMA: | 43.38 | Sell |
Constellation Software Earnings Growth & CSU.TO Earnings Dates
- Analysts estimate an earnings increase this quarter of $7.37 per share, a decrease next quarter of $0.66 per share, an increase this year of $25.68 per share, and an increase next year of $23.06 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Constellation Software Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 19 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |